Literature DB >> 6237105

Domain structure of rabbit hemopexin. Isolation and characterization of a heme-binding glycopeptide.

W T Morgan, A Smith.   

Abstract

Plasmin preferentially cleaves rabbit hemopexin at a single site, generating two nondisulfide-linked carbohydrate-containing fragments. In contrast, heme-hemopexin is almost totally resistant to this enzyme and is more resistant than the apoprotein to digestion by trypsin, chymotrypsin, papain, subtilisin, and proteinase K as well. Plasmin digestion dramatically shortens the plasma clearance time of the molecule. The larger glycopeptide (I), shown to be derived from the amino terminus of the parent molecule by sequence analysis, has a molecular weight near 35,000 with a pI of 5.0. It binds 1 mol of heme per mol in a manner analogous to intact hemopexin, molecular weight near 60,000 and pI 5.8. The smaller glycopeptide (II) has a molecular weight near 25,000, a pI of 6.4, and does not bind heme. Of the four oligosaccharides of rabbit hemopexin, peptide I contains three oligosaccharides and peptide II contains one. At micromolar concentrations, the two peptides migrate together during centrifugation through sucrose gradients in the presence, but not in the absence, of heme. Peptide I has a far UV circular dichroism spectrum indicating it has some alpha-helical and extensive nonrepeating peptide structures whereas peptide II appears to be almost exclusively in a beta-sheet conformation. Peptide II is responsible for most of the positive ellipticity at 231 nm of native apohemopexin, but the increase in ellipticity at 231 nm characteristic of heme-hemopexin is not seen when peptide I binds heme, even in the presence of peptide II.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6237105

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Further characterization of structural determinants of rabbit hemopexin function.

Authors:  P Muster; F Tatum; A Smith; W T Morgan
Journal:  J Protein Chem       Date:  1991-02

2.  Accelerated autoxidation and heme loss due to instability of sickle hemoglobin.

Authors:  R P Hebbel; W T Morgan; J W Eaton; B E Hedlund
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

3.  Identification of oxidative modifications of hemopexin and their predicted physiological relevance.

Authors:  Peter Hahl; Rachel Hunt; Edward S Bjes; Andrew Skaff; Andrew Keightley; Ann Smith
Journal:  J Biol Chem       Date:  2017-06-08       Impact factor: 5.157

4.  Heme binding by hemopexin: evidence for multiple modes of binding and functional implications.

Authors:  N Shipulina; A Smith; W T Morgan
Journal:  J Protein Chem       Date:  2000-04

5.  Emergence of the acute-phase protein hemopexin in jawed vertebrates.

Authors:  Helen Dooley; E Bryan Buckingham; Michael F Criscitiello; Martin F Flajnik
Journal:  Mol Immunol       Date:  2010-09-29       Impact factor: 4.407

Review 6.  Dealing with iron: common structural principles in proteins that transport iron and heme.

Authors:  Heather M Baker; Bryan F Anderson; Edward N Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-17       Impact factor: 11.205

7.  Contributions of tryptophan side chains to the far-ultraviolet circular dichroism of proteins.

Authors:  R W Woody
Journal:  Eur Biophys J       Date:  1994       Impact factor: 1.733

8.  Affinity, conservation, and surface exposure of hemopexin-binding proteins in Haemophilus influenzae.

Authors:  J C Wong; R Patel; D Kendall; P W Whitby; A Smith; J Holland; P Williams
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

9.  Expression of the haemopexin-transport system in cultured mouse hepatoma cells. Links between haemopexin and iron metabolism.

Authors:  A Smith; B E Ledford
Journal:  Biochem J       Date:  1988-12-15       Impact factor: 3.857

10.  Antioxidant protection by haemopexin of haem-stimulated lipid peroxidation.

Authors:  J M Gutteridge; A Smith
Journal:  Biochem J       Date:  1988-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.